David Roman
Stock Analyst at Goldman Sachs
(0)
# 2857
Out of 5,298 analysts
35
Total ratings
29.41%
Success rate
8.14%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
KMTS Kestra Medical Techs | Initiates Coverage On: Neutral | 24 | 24.06 | -0.25% | 1 | Mar 31, 2025 | |
HQY HealthEquity | Maintains: Neutral | 107 94 | 83.87 | 12.08% | 2 | Mar 27, 2025 | |
GEHC GE HealthCare Techs | Upgrades: Buy | 85 100 | 71.93 | 39.02% | 2 | Mar 11, 2025 | |
ABT Abbott Laboratories | Maintains: Strong Buy | 138 154 | 132.29 | 16.41% | 2 | Mar 4, 2025 | |
TDOC Teladoc Health | Maintains: Buy | 16 13 | 7.44 | 74.73% | 3 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 42 24 | 17.63 | 36.13% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 63 71 | 71.94 | -1.31% | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 64 55 | 37.8 | 45.5% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 42 | 31.49 | 33.38% | 3 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 91 124 | 104.85 | 18.26% | 2 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 58 80 | 54.84 | 45.88% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 384 427 | 368 | 16.03% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 81 90 | 72.93 | 23.41% | 3 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 90 | 99.03 | -9.12% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 500 | 499.27 | 0.15% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 274 | 221.2 | 23.87% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 129 | 113.06 | 14.1% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 83 | 88.5 | -6.21% | 1 | May 30, 2024 |